Authors
Wilber Cruz is senior QC Microbiology manager at Abzena.
Gina Marsee is the Director, Compendial Compliance and Advocacy at Merck located in West Point, PA, USA. She holds a bachelor’s degree in Chemistry & Biology from the University of Tennessee and has worked in the pharmaceutical industry for 30+ years holding various leadership roles within Quality, Compliance, and Regulatory Affairs.
Patrick Falvey is principal consultant 2 of Chemistry Manufacturing and Controls, Sia/LBG.
Angela Strzelecki, PhD, is senior vice president of the Roquette Group and CEO of Roquette’s Health & Pharma Solutions Business Unit
Yeli Zhang, PhD, is Application and Innovation Technical Service Manager, Roquette.
Bob Sulouff is Sr. Manager Regulatory Affairs, Health & Pharma Solutions, ROQUETTE Americas. Bob has over 25 years’ experience in Regulatory Affairs and Quality, primarily focused on excipients. He is a member of Roquette’s Health and Pharma Solutions Regulatory team, where he advocates for value added pharma regulatory solutions.
DMSO as Skin Penetration Enhancer
Candy Reynolds Cummings spent 15 years at GlaxoSmithKline starting as an analytical chemist and working up to QA Validation Manager in the OTC area (specifically oral care). Currently working at Evonik as the Regulatory and Product Stewardship Manager supporting the business line Silica for regulations in US, Canada, and Mexico.
Philip Hoersch is Director, Quality Assurance, Process Performance & System Compliance, Vetter.
Jérôme Barra is vice president Global Marketing Taste, HNC at dsm-firmenich.
Radoslaw Kaczanowski is head of Global Project Management at Recipharm.
Dr. Michelle Sestak joined HORIBA in 2012 after earning a PhD in physics from the University of Toledo. She specialized in spectroscopic ellipsometry for cadmium telluride thin-film solar cells. Starting as a thin film applications scientist, she later expanded into Raman spectroscopy and now works as a Raman and thin films applications scientist.
Ken Boda is dissolution product specialist at Agilent Technologies.
Diana Russo has more than 20 years of experience in the pharmaceutical industry. She has built her career in the areas of computer system validation, IT quality, and computer systems quality assurance. And while her current role focuses on data integrity, DI has been an important driving force throughout her entire career. She is an audit trail review subject matter expert, a leader in process improvement, and happily challenges the status quo.
Akanksha Prasad, MS, is a chemical and bioprocess engineer with over nine years of experience in chemical, biologics, and pharmaceutical process development. Her expertise spans mRNA, vaccines, and biologics, with a focus on technology transfer, PAT, scale-up, purification, and regulatory compliance. She holds a Master’s in Chemical Engineering with a biopharma specialization from the Illinois Institute of Technology, Chicago, and a Bachelor’s in Chemical Engineering from India.
Abdul W. Basit is a professor in the Department of Pharmaceutics, UCL School of Pharmacy, University College London and co-founder of FABRX Ltd.
Jyothi Gautam is senior manager technical salesand works closely with distributors, brand owners and manufacturers and is responsible for providing technical, regulatory and commercial support.
Aimee Penko is an engineering execution manager for Arcadis.
Joe Compton is senior director, Business Development and Alliance Management, TPU (Tjoapack US).
Robert Dream is managing director of HDR Company and a member of PharmTech’s Editorial Advisory Board.
Gary Ritchie, InfraTrac [email protected], is director of Scientific Affairs at InfraTrac.
Kimberly Salgado is Head of Centre for Biosimilar Drug Development, ICON plc